Akoya Biosciences’ $151.3 Million Initial Public Offering

Davis Polk advised the representatives of the several underwriters in the offering.Akoya Biosciences, Inc. executed its $151.3 million initial public offering of 7,567,000 shares of common stock. Akoya…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now